NAMSA Blog Impact of FDA Changes on MedTech Research

Will Proposed Cuts at the FDA Slow Down Your Clinical Research Projects? Join Doctors Leon, Granada, and Ouriel with Dr. Jeff Shuren, former Director of (CDRH) at the FDA, for an interactive discussion on current challenges facing the MedTech industry, clinical investigators, and regulators. Changes at the FDA-current and potential-will require new ways of interacting Read more...The post Impact of FDA Changes on MedTech Research appeared first on NAMSA.